https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-09 / Br. J. Cancer 2007 Nov;97(9):1251-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-09 / Br. J. Cancer 2007 Nov;97(9):1251-92007-10-09 00:00:002019-02-15 08:50:17Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-05 / Cancer Immunol. Immunother. 2008 May;57(5):611-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-05 / Cancer Immunol. Immunother. 2008 May;57(5):611-222007-09-05 00:00:002007-09-05 00:00:00An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-292007-08-01 00:00:002007-08-01 00:00:00Benefits of superficial hyperthermia treatment planning: five case studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Expert Rev Vaccines 2007 Aug;6(4):617-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Expert Rev Vaccines 2007 Aug;6(4):617-332007-08-01 00:00:002007-08-01 00:00:00Dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Cancer Res. 2007 Aug;67(15):7477-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Cancer Res. 2007 Aug;67(15):7477-862007-08-01 00:00:002019-02-15 08:50:19A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-07-15 / Cancer Res. 2007 Jul;67(14):6531-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-07-15 / Cancer Res. 2007 Jul;67(14):6531-42007-07-15 00:00:002007-07-15 00:00:00Development of vaccines for high-risk ductal carcinoma in situ of the breast
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-07-01 / Anticancer Res. 2007 Jul-Aug;27(4B):2121-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-07-01 / Anticancer Res. 2007 Jul-Aug;27(4B):2121-92007-07-01 00:00:002007-07-01 00:00:00Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-06-01 / J. Exp. Clin. Cancer Res. 2007 Jun;26(2):201-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-06-01 / J. Exp. Clin. Cancer Res. 2007 Jun;26(2):201-72007-06-01 00:00:002007-06-01 00:00:00Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):345-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):345-82007-03-01 00:00:002007-03-01 00:00:00Counterpoint: Hyperthermia with radiation therapy for chest wall recurrences
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):339-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):339-442007-03-01 00:00:002007-03-01 00:00:00Point: Hyperthermia with radiation for chest wall recurrences
